The GLP Chart ranking

Every US GLP-1 telehealth program, scored and ranked. The rank is the published GLP Chart score across five equal-weighted pillars. Scores run 5.8 to 8.2 out of 10.

Top of the chart, June 2026: Mochi Health

Three programs tie for the top score this month at 8.2: Mochi Health, Sesame Care and LifeMD. We break the tie on price predictability, so Mochi Health takes the number-one slot. Mochi Health holds one flat compounded price at every dose with no lock-in, the most transparent of the three, while Sesame Care runs visit-by-visit and LifeMD pairs a money-back guarantee with genuine branded Novo and Lilly supply. Any of the three is a defensible first pick.

The same compounded semaglutide runs about $149 to $299 a month across these programs, a real spread for the identical molecule before any intro pricing. Branded Wegovy and Zepbound run past $1,000 in cash.

The ranking, June 2026

Scores out of 10, equal-weighted across five dimensions. How we score

RankProgramScoreThis month
1Mochi HealthOne flat price covers every dose, no tier jumps.8.2new
2Sesame CarePay-per-visit care with medication sold near wholesale.8.2new
3LifeMDBrand-name supply with an outcomes-based money-back guarantee.8.2new
4Noom MedBehavioral program built around the medication, billed quarterly.8new
5Henry MedsPrices show only at signup; sublingual option for needle-free.8new
6MedviFlat refill price that holds as your dose climbs.7.8new
7Push HealthMarketplace doctors write the script, you fill it yourself.7.7new
8Costco / Success by SesameDiscounted member care plus brand-name medication at Costco.7.6new
9Ro BodyPolished app with brand-name supply from the makers.7.5new
10Ivim HealthCash for compounded, insurance route for brand-name.7.4new
11GoodRx for Weight LossLow-cost telemedicine subscription with transparent published medication prices.7.4new
129amHealthBuilt for diabetes and heart-risk patients, not weight loss alone.7.3new
13Hone HealthMen's hormone program that pairs GLP-1 with TRT.7.3new
14Strut HealthCompounded injectable and oral semaglutide from $149/mo published price.7.2new
15Lemonaid HealthOne platform if you already manage other meds here.7.2new
16Walgreens Weight ManagementBrand-name prices shown upfront, pick up at the counter.7.2new
17Hims & HersFast async signup, brand-name only, no compounded route.7new
18Klarity Health7new
19KnownwellPrimary care plus obesity medicine in one insured practice.6.9new
20FoundWidest drug catalog, but the best price needs a 12-month plan.6.8new
21EdenAggressive intro price behind a heavier upsell flow.6.8new
22LifeforceLongevity platform; medication priced only once you join.6.8new
23ShedCompounded semaglutide with a weight-loss guarantee.6.8new
24Amazon PharmacyUpfront cash prices with fast nationwide delivery.6.4new
25CalibrateCoaching-heavy reset for insured patients who want structure.6.2new
26Sam's Club Member HealthPill at a low member price, plus the Well health app.6new
27WeightWatchers ClinicBehavioral framework attached, but canceling means calling support.5.8new

How prices got here: the compounding cliff

  1. 2024
    A stable cash band. Compounded semaglutide settles around $199 to $279 a month across the early telehealth programs.
  2. Feb 2025
    Shortage declared over. The FDA says the semaglutide shortage is resolved. That starts the clock on compounding limits.
  3. Apr to May 2025
    Compounding winds down. 503A pharmacy compounding restrictions take effect in April, 503B in May. The cheap compounded supply starts to narrow.
  4. Feb 2026
    A brief price floor. One program lists a $99 oral compounded pill. It is withdrawn within days under manufacturer legal pressure. It was never a stable market price.
  5. Jun 2026
    Where it landed. Surviving compounded programs settle around $178 to $209 a month, while branded Wegovy and Zepbound run past $1,000 in cash.

How we rank

Every program earns a 0 to 10 score across five equal-weighted pillars: pricing, cancellation terms, onboarding speed, medication options, and member feedback. The ranking is that score, sorted. We verify prices against each program's published page every Monday. See the full methodology.

Some visit links earn us a commission. Rankings are set from the score before any program is contacted, and a commission never changes a score or a position. Affiliate disclosure.

Frequently asked questions

How are GLP-1 programs scored?

Each program gets a published 1-to-10 GLP Chart score across five dimensions: pricing transparency, cancellation terms, onboarding speed, medication options and member feedback. Scores currently run 5.8 to 8.2. Rankings are the score sorted, re-scored monthly, and a commission never changes a score or a position.

What is the price spread across ranked programs?

Compounded semaglutide starts at about $149 a month at the cheapest cash-pay program and runs to about $299 a month at a maintenance dose. The cheapest program that holds one flat price at every dose with no lock-in is Mochi Health at $178 a month. The highest headline price on the chart is $448 a month at LifeMD. Every headline is a program's cheapest all-in route, so a dearer drug at the same program can cost more. Prices are verified against each program's published pricing every Monday.

How often does the ranking change?

The full re-score runs monthly; the current edition is the June 2026 ranking. Prices are checked every Monday in between, and a price change large enough to move a score is applied at the next monthly re-score with the change noted on the program page.

For picks by situation rather than by score, see best GLP-1 programs by use case.

Why you can trust GLP ChartSame scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.